EHN’s feedback to the Commission’s combined roadmap / inception impact assessment on the evaluation and revision of the general pharmaceutical legislation.
In the fourth quarter of 2021, the European Commission will open a public consultation.
Adopted on 25 November 2020, the Pharmaceutical Strategy for Europe aims at creating a future proof regulatory framework and at supporting industry in promoting research and technologies that actually reach patients in order to fulfill their therapeutic needs while addressing market failures. It will also take into account the weaknesses exposed by the COVID-19 pandemic and take appropriate actions to strengthen the system.
It will be based on four pillars, which include legislative and non-legislative actions.
Click here for a detailed background and related documents.